Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Gabapentin for Smoking Abstinence

NCT00578552 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.

NCT NCT00578552
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00578552 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Gabapentin for Smoking Abstinence
Lead sponsor
Mayo Clinic
Phase
Phase 2
Overall status
Completed
Start date
October 31, 2007
Completion date
May 31, 2009
Enrollment
80 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cigarette smoking, tobacco use